Healthcare
Codexis, Inc.
CDXSPrice is delayed.
About Codexis, Inc.
Codexis makes enzymes, which are biological molecules that speed up chemical reactions, for use in manufacturing medicines and drugs. The company uses a technology called CodeEvolver to discover and improve these enzymes so they work better for drug makers. They also developed a manufacturing platform called ECO Synthesis that helps companies produce certain types of RNA-based medicines more efficiently. Codexis has partnerships with pharmaceutical companies including Pfizer to apply its enzyme technology to drug production.
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore